NBP downregulated the important C. albicans biofilm- and hyphal-related genes ECE1, HWP1, and UME6. Therefore, NBP could be a promising candidate for therapy against candidiasis, which also has the potential to serve as a broad-spectrum anti-biofilm agent against both Gram-positive and Gram-negative bacteria. Here, ECE1 is linked to candidiasis.